Table 1.
Characteristics of Participants at Baseline (n = 2,191), Health, Aging, and Body Composition Study, 1997–1998
| Characteristic | No. or Mean (SD) | % |
| Sociodemographic factors | ||
| Age, years | 73.5 (2.8) | |
| Female gender | 1,211 | 55.3 |
| Black race | 900 | 41.1 |
| Memphis, Tennessee, study site | 1,124 | 51.3 |
| Education | ||
| Less than high school | 532 | 24.3 |
| High school graduation | 734 | 33.6 |
| Postsecondary education | 920 | 42.1 |
| Smoking status | ||
| Never smoker | 1,015 | 46.3 |
| Former smoker | 955 | 43.6 |
| Current smoker | 221 | 10.1 |
| Alcohol consumption, drinks/week | ||
| <1 | 1,534 | 70.3 |
| 1–7 | 481 | 22.1 |
| >7 | 166 | 7.6 |
| Physical activity, kcal/weeka | ||
| <500 | 1,148 | 52.4 |
| 500–1,500 | 596 | 27.2 |
| ≥1,500 | 447 | 20.4 |
| Hypertensionb | 1,002 | 46.1 |
| Diabetes mellitus | 292 | 13.3 |
| Body mass indexc | 27.4 (4.9) | |
| Systolic blood pressure | 136 (21) | |
| Diastolic blood pressure | 72 (12) | |
| Lipoprotein level, mmol/L | ||
| Total cholesterol | 5.31 (0.98) | |
| High density lipoprotein cholesterol | 1.42 (0.44) | |
| Low density lipoprotein cholesterol | 3.19 (0.88) | |
| Triglyceridesd | 1.31 (0.98–1.81) | |
| 10-year FRS, %e | 16.6 (2.9) | |
| Category of FRS | ||
| <5% | 297 | 13.6 |
| 5–9.9% | 523 | 23.9 |
| 10–19.9% | 853 | 38.9 |
| ≥20% | 518 | 23.6 |
| Creatinine level, mmol/Ld | 88.4 (79.6–97.2) | |
| Medication use | ||
| Lipid-lowering drugs | 229 | 10.5 |
| Angiotensin-converting enzyme inhibitors | 273 | 12.5 |
| Hormone replacement therapy | 285 | 13.0 |
| Aspirin | 412 | 18.8 |
Abbreviations: FRS, Framingham Risk Score; SD, standard deviation.
Physical activity was assessed by questionnaire. Participants were asked about all types of walking and exercise performed in the prior week (14).
Defined as self-reported hypertension and use of antihypertensive medication or measured blood pressure ≥140/90 mm Hg.
Weight (kg)/height (m)2.
Expressed as median (25th–75th percentiles). A Mann-Whitney rank-sum test was performed.
10-year risk of coronary heart disease according to Adult Treatment Panel III FRS (18).